ELIZABETH FERRARA: Open Payments
NPI 1891405973 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 31 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $86 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $81 |
| Astellas Pharma US Inc | 3 | $60 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Lilly USA, LLC | 2 | $35 |
| Hologic Sales and Service, LLC | 1 | $31 |
| ABBVIE INC. | 2 | $29 |
| Tempus AI, Inc | 1 | $22 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
Products named: Cologuard Collection Kit, Veozah, MYFEMBREE, ZEPBOUND, APTIMA, LILETTA, XT CDX, Quviviq.
Industry payments across PA — which companies pay providers there.
